Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis
暂无分享，去创建一个
K. Eguchi | K. Ichinose | M. Umeda | S. Fukui | A. Nishino | T. Koga | S. Kawashiri | N. Iwamoto | M. Tamai | Hideki Nakamura | T. Origuchi | A. Kawakami | A. Mizokami | Y. Ueki | K. Terada | A. Okada | K. Fujikawa | T. Aramaki | Y. Hirai | Y. Horai | Y. Nakashima | M. Nakashima | F. Nonaka | Takahisa Suzuki